WASHINGTON--(BUSINESS WIRE)--The Institute for Patient Access today released “Protecting Cancer Care: Improving Transparency and Patient Access,” a white paper authored by the Alliance for Patient Access’ Oncology Therapy Access Physicians Working Group. The white paper, which reflects its oncologist authors’ combined experiences, explores how insurers’ cost-saving strategies may impede cancer patients’ access to the care they need.
“Since we first formed the oncology working group, these physicians have expressed concerns about how strategies designed to cut health care costs may interfere with their patients’ access to life-saving therapies,” explained David Charles, M.D., chairman of the Alliance for Patient Access. “This white paper articulates those concerns so that policymakers and fellow physicians can understand the challenges cancer patients face.”
The white paper’s authors first address specialty tiers, which often require patient cost-sharing that may effectively price patients out of treatment. Prolonged prior authorization processes, the paper notes, can also complicate treatment by introducing long waiting periods for therapies that cancer patients need immediately. The authors also express a desire for more equal insurance coverage for therapy types, both oral and infused, and treatment locations, such as a community care centers or large hospitals.
Several states have passed legislation requiring standard, electronic prior authorization approvals. Oral parity legislation has also made headway in 33 states and the District of Columbia.
“Protecting Cancer Care” calls for greater transparency regarding patient costs and co-pays. It also encourages policymakers and citizens to promote patient-friendly insurance policies that support access to cancer therapies.
About IfPA. The Institute for Patient Access (IfPA) is a physician-led policy research organization dedicated to maintaining the primacy of the physician-patient relationship in the provision of quality healthcare. In furtherance of its mission, IfPA produces educational materials and programming designed to promote informed discussion about patient access to approved therapies and appropriate clinical care. Established in 2012 by the leadership of the Alliance for Patient Access, IfPA is a 501(c)(3) public charity non-profit organization.